FIELD: medicine.
SUBSTANCE: biochemical fasting blood analysis is conducted to measure glucose and alanine aminotransferase in a combination with ultrasonic examination of: the liver to determine the echo-producing structure, the fasting pancreas to determine a size of its head, and the thyroid to determine its volume. The derived data are used to calculate a diagnostic coefficient by formula P=1/1+e-z. If the calculated value P≥0.5, metabolic syndrome is diagnosed, while P<0.5 shows the absence of metabolic syndrome.
EFFECT: method enables higher accuracy of diagnosing metabolic syndrome by measuring biochemical and ultrasonic values.
5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIAGNOSING METABOLIC SYNDROME | 2010 |
|
RU2444298C1 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANYING METABOLIC SYNDROME | 2018 |
|
RU2686042C1 |
| METHOD OF ESTIMATING RISK OF METABOLIC SYNDROME DEVELOPMENT IN CHILDREN BASING ON GENETIC AND BIOCHEMICAL MARKERS | 2012 |
|
RU2492485C1 |
| METHOD OF TREATING ABDOMINAL OBESITY IN CASE OF METABOLIC SYNDROME | 2013 |
|
RU2548709C1 |
| METHOD FOR DETERMINING INSULIN-RESISTANCE | 2013 |
|
RU2541102C1 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME WITH VITAMIN D DEFICIENCY | 2018 |
|
RU2694842C1 |
| METHOD FOR DETERMINING METABOLICALLY HEALTHY AND METABOLICALLY UNHEALTHY OBESITY IN YOUNG AND MIDDLE-AGED WOMEN | 2023 |
|
RU2822965C1 |
| METHOD OF SELECTING MEN AT PRE-DIABETES RISK GROUP AND TYPE 2 DIABETES MELLITUS | 2017 |
|
RU2695322C2 |
| METHOD OF TREATING METABOLIC SYNDROME IN EMOTIOGENIC TYPE OF EATING BEHAVIOUR | 2015 |
|
RU2591811C1 |
| METHOD FOR NONINVASIVE SCREENING FOR THE PRESENCE OF INSULIN RESISTANCE USING THE ANTHROPOMETRIC INDEX “BREAST CIRCUMFERENCE TO HEIGHT” IN ADOLESCENTS | 2021 |
|
RU2778004C1 |
